News and Trends 6 Jul 2023 £100M LifeArc program aims to help people living with rare diseases …rare disease, with approximately 3.5 million people in the U.K. affected. With more than 7,000 rare diseases identified, there is a need for new treatments and technologies to speed up… July 6, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jul 2019 Dutch Antibodies for Autoimmune Diseases Boosted by €15M Series A The Dutch biotech Citryll has raised €15M to develop antibodies that could fight autoimmune and inflammatory diseases more effectively than current treatments by inhibiting the innate immune system. The Series… July 4, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 24 Apr 2023 Life Biosciences gene therapy data shows visual function restored in primates …development of our scientific platform to address diseases of aging and restore human health.” Life Biosciences tackling range of aging diseases Life Biosciences is advancing its cellular rejuvenation capabilities across… April 24, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 9 Oct 2018 How to Capitalize on Opportunities in Underserved Disease Areas …biotech companies and investors. Traditionally diseases are ‘underserved’ because they are complex and we don’t understand them well enough, such as some of the more common autoimmune diseases, or because… October 9, 2018 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2019 €48M Series B Fuels Immunotherapies for Cancer and Autoimmune Diseases ImCheck Therapeutics has raised a Series B round worth €48M to fund the development of first-in-class immunotherapies that treat cancer and autoimmune diseases by targeting a rare type of immune… December 4, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 26 Oct 2016 Proteins can now Sing about their Anomalies to help cure Diseases …its features. This project could become a powerful new tool to detect anomalies that cause all kinds of diseases. Protein fold assignment is a notoriously tricky area of research in… October 26, 2016 - 3 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 18 Nov 2024 What is Abcam’s founder, Jonathan Milner, up to? …AI Drug discovery, rare diseases Healx specializes in the use of artificial intelligence (AI) to accelerate the discovery and development of treatments for rare diseases with its platform Healnet. One… November 18, 2024 - 17 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2025 First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics? …males worldwide and around 150 people in the U.S. making it an ultra-rare disease, and so, ultra-hard to treat. Ultra-rare diseases: why are they so hard to treat? Ultra-rare diseases… September 29, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 28 Nov 2017 Reviewing Gene Therapy: How Close is Biotech to Genetic Cures? Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix each of them. Here’s a review of biotech’s progress. Biotech is arguably built on… November 28, 2017 - 8 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jul 2022 Almirall launches new call to find innovative therapies for skin diseases A new call for new therapies to treat skin diseases has been launched by global Spanish-based biopharmaceutical company, Almirall, S.A. This is the seventh call through AlmirallShare – an open… July 21, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
More News! 16 Apr 2018 Epitopes Come to the Rescue for One of the Most Common Autoimmune Diseases The British-Belgian biotech Apitope has obtained positive Phase I results for its first-in-class treatment for Graves’ disease, one of the most common autoimmune diseases. Apitope has obtained positive clinical results… April 16, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 22 Sep 2022 New phase 1 biomarker results reported by Glyscend Therapeutics for diabetes drug …GLY-200 for the treatment of T2D and has initiated a phase 2 clinical trial in patients with the condition. Glyscend says that metabolic surgery is a highly effective but invasive… September 22, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email